Clinical Trial of Efficacy, Safety, and Immunogenicity of Gam-COVID-Vac Vaccine Against COVID-19 in Belarus
Clinical trial NCT04564716 · UNKNOWN
Trial details
- NCT number
- NCT04564716
- Sponsor
- Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-28
- Primary completion
- 2021-03-28
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.